<ul id="eack0"><dfn id="eack0"></dfn></ul>
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"><input id="eack0"></input></strike>
    
    
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"></strike>
    歡迎來到上海通蔚!

    021-54845833/15800441009

    品質(zhì)保證 · 通蔚試劑

    當前位置: 首頁 > 科研產(chǎn)品 > 科研抗體 > 一抗 > 小鼠抗TBC1D13單克隆抗體

    產(chǎn)品中心

    最新產(chǎn)品

    • 小鼠抗TBC1D13單克隆抗體

      規(guī)格:
      價格:
      • 品牌 : 通蔚生物
      • 目錄號 : TW12248
      • 應用 : 僅供科研使用
      • 貨期 : 現(xiàn)貨
      • 規(guī)格 :100ul
    • 商品詳情
    • 參考文獻
    • 說明書下載
    • 商品評論0
    • 相關(guān)產(chǎn)品

    中文名稱: 小鼠抗TBC1D13單克隆抗體

    英文名稱: Anti-TBC1D13 mouse monoclonal antibody

    別    名: RP11-545E17.5

    抗    原: TBC1D13

    儲    存: 冷凍(-20℃) 避光

    宿    主:
    Mouse

    反應種屬: Human

    相關(guān)類別: 一抗

    標 記 物: Unconjugate

    克隆類型: mouse monoclonal

    技術(shù)規(guī)格

    Background:

    TBC1D13 (TBC1 domain family member 13) is a 400 amino acid protein that contains one Rab-GAP TBC domain. Existing as two alternatively spliced isoforms, TBC1D13 may act as a GTPase-activating protein for Rab family proteins. The gene that encodes TBC1D13 contains 23,229 bases and maps to human chromosome 9q34.11. Housing over 900 genes, chromosome 9 comprises nearly 4% of the human genome. Hereditary hemorrhagic telangiectasia, which is characterized by harmful vascular defects and Familial dysautonomia, are both associated with chromosome 9. Mutations in DFNB31, located on human chromosome 9, are associated with Usher syndrome type 2, which is characterized by severe rod-cone dystrophy and varying degrees of hearing impairment. Notably, chromosome 9 encompasses the largest interferon family gene cluster.

    Applications:

    WB, IHC

    Name of antibody:

    TBC1D13

    Immunogen:

    Fusion protein of human TBC1D13

    Full name:

    TBC1 domain family, member 13 (TBC1D13), transcript variant 1

    Synonyms:

    RP11-545E17.5

    SwissProt:

    Q9NVG8

    IHC positive control:

    carcinoma of human liver tissue and carcinoma of human thyroid tissue

    IHC Recommend dilution:

    30-150

    WB Predicted band size:

    47 kDa

    WB Positive control:

    HepG2, Hela, SVT2, A549, COS7, Jurkat, MDCK, PC12, MCF-7 cell lysates

    WB Recommended dilution:

    1000-5000



    產(chǎn)品掃碼查看詳情
    手機掃描查看
    <ul id="eack0"><dfn id="eack0"></dfn></ul>
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"><input id="eack0"></input></strike>
    
    
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"></strike>